Immutep
IMMP
#7707
Rank
C$0.49 B
Marketcap
C$3.36
Share price
-5.43%
Change (1 day)
13.52%
Change (1 year)

Earnings for Immutep (IMMP)

Earnings in 2024: -C$39.25 Million

According to Immutep's latest financial reports the company's current earnings are -C$0.01 Million. In 2024 the company made an earning of -C$39.25 Million a decrease over its 2023 earnings that were of -C$36.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immutep from 2008 to 2024

Annual earnings

Year Earnings Change
2024-C$39.25 Million7.23%
2023-C$36.61 Million19.67%
2022-C$30.59 Million-0.9%
2021-C$30.87 Million141.19%
2020-C$12.8 Million-27.85%
2019-C$17.74 Million36.56%
2018-C$12.99 Million21.61%
2017-C$10.69 Million-83.52%
2016-C$64.81 Million89.45%
2015-C$34.21 Million97.68%
2014-C$17.31 Million-9.05%
2013-C$19.03 Million-32.33%
2012-C$28.12 Million-9.61%
2011-C$31.11 Million48.52%
2010-C$20.95 Million538.22%
2009-C$3.29 Million32.05%
2008-C$2.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Illumina
ILMN
C$1.36 B-10,922.68%๐Ÿ‡บ๐Ÿ‡ธ USA
HTG Molecular Diagnostics
HTGM
-C$26.88 Million 112.36%๐Ÿ‡บ๐Ÿ‡ธ USA
FibroGen
FGEN
-C$0.18 Billion 1,298.90%๐Ÿ‡บ๐Ÿ‡ธ USA